BACKGROUND Transitional cell carcinoma of the bladder, the second most common urologic malignancy, is amenable to early diagnosis. This study presents the potential prognostic benefit for a less invasive modification to the standard endoscopic approach. OBJECTIVES To evaluate the risk index for the progression and recurrence of additional tumors detected with narrow-band imaging (NBI) cystosc...

Following the seminal trial conducted by the European Organisation for Research and Treatment of Cancer (EORTC) and the National Cancer Institute of Canada (NCIC), concurrent temozolomide and radiotherapy has become the new standard of care for patients with newly diagnosed glioblastoma multiforme (GBM). Investigation of emerging therapies (which are now used as salvage therapy) such as small-m...

Cancer treatment for elderly patients is often complicated by poor physical condition, impaired functioning and comorbidities. Patient reported health related quality of life (HRQOL) can contribute to decisions about treatment goals and supportive therapy. Knowledge about factors influencing HRQOL is therefore needed for the development of supportive measures and care pathways. An exploratory s...

AIMS: To present the first cross-culture validation of the European organization for research and treatment of cancer (EORTC) quality of life questionnaires, the EORTC-QLQ-C30, and the QLQ-H&N35 in India. SETTINGS AND DESIGN: These questionnaires were translated into two vernacular languages and pilot test was done on 15 patients. Two hundred head and neck cancer patients completed the QLQ-C30 ...

uygulanmış olan hastalarda yaşam kalitesi düzeyinin ve kalitesine etki eden faktörlerin araştırılması amaçlandı.GEREÇ VE YÖNTEM: Tanımlayıcı nitelikte kesitsel bir araştırma çalışmanın örneklemini, mastektomi ya da meme koruyucu cerrahi yapılmış, Evre I-III, 21-80 yaş arasında toplam 110 kanseri hastaları oluşturdu. Anket verileri Haziran 2020-Ağustos 2020 tarihleri elde edildi. Araştırmada “Av...

Based on the results of European Organization for Research and Treatment of Cancer (EORTC) 18991 trial, the US Food and Drug Administration (FDA) approved PEG-interferon α-2b (PEG-IFN) (Sylatron) as adjuvant therapy for high-risk melanoma. The EORTC 18991 trial was an open-label study of resectable stage III melanoma with 1,256 patients who were randomized to observation-alone or to treatment w...

The aim of the study was to investigate the extent to which the symptoms experienced by advanced cancer patients were covered by the nursing records. On the day of the first contact with our palliative care department, a nursing record was taken, and on this or the following day, 56 patients filled in the questionnaires EORTC Quality of Life Questionnaire (EORTC QLQ-C30), Edmonton Symptom Asses...

● Of the 59 publications included in this review, the majority of publications (n=44) reported data on the impact on NSCLC on patients overall HRQoL. — Larsson (2012) and Lee (2011) found that stage III-IV patients reported a significant reduction in global or overall health, as defined by the EORTC QLQ-C30 and WHOQOLBREF respectively, when compared to the general population or healthy controls...

Administration of parenteral iron and mortality among hemodialysis patients. J Am Soc Nephrol 2004;15:1623–32. 24 Bokemeyer C, Aapro MS, Courdi A et al; European Organisation for Research and Treatment of Cancer (EORTC). Taskforce for the Elderly. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update. Review. Eur J Cancer 2007;43:258–70. 25 Rizzo J...